thiazoles has been researched along with Arthropathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Griffith, EH; Gruen, ME; Lascelles, BD; Simpson, W; Thomson, AE | 1 |
Braddock, M; Clifton, AD; Lopez-Castejon, G; Pelegrin, P; Surprenant, A; Theaker, J | 1 |
1 trial(s) available for thiazoles and Arthropathies
Article | Year |
---|---|
Criterion Validation Testing of Clinical Metrology Instruments for Measuring Degenerative Joint Disease Associated Mobility Impairment in Cats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Diseases; Cats; Cross-Over Studies; Double-Blind Method; Female; Joint Diseases; Male; Meloxicam; Mobility Limitation; Motor Activity; Severity of Illness Index; Thiazines; Thiazoles; Treatment Outcome | 2015 |
1 other study(ies) available for thiazoles and Arthropathies
Article | Year |
---|---|
P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases.
Topics: Adenosine Triphosphate; Animals; Blotting, Western; Cathepsin B; Cathepsins; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Interleukin-1beta; Joint Diseases; L Cells; Macrophages; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Receptors, Tumor Necrosis Factor; Thiazoles | 2010 |